SARS-CoV-2 IgM/IgG Antibody
inoa huahana
HWTS-RT090-SARS-CoV-2 IgM/IgG Antibody Detection Kit (Ke ʻano gula colloidal)
Palapala
CE
Epidemiology
ʻO ka maʻi ʻo Coronavirus 2019 (COVID-19), he maʻi maʻi maʻi i hoʻokumu ʻia e ka maʻi me ka coronavirus novel i kapa ʻia ʻo Severe Acute Respiratory Syndrome Corona-Virus 2 (SARS-CoV-2). ʻO SARS-CoV-2 kahi coronavirus hou ma β genus a hiki i ke kanaka ke maʻalahi iā SARS-CoV-2. ʻO nā kumu nui o ka maʻi i hoʻopaʻa ʻia i nā mea maʻi COVID-19 a me ka mea lawe asymptomatic o SARS-CoV-2. Ma muli o ka noiʻi epidemiological o kēia manawa, ʻo ka manawa incubation he 1-14 mau lā, ʻo ka hapa nui he 3-7 mau lā. ʻO nā hiʻohiʻona nui o ke kuni, ka ʻū maloʻo, a me ka luhi. ʻO kahi helu liʻiliʻi o nā poʻe maʻi e hele pū me ka nasal congestion, runny ihu, ʻeha ʻāʻī, myalgia a me ka maʻi maʻi.
Nā ʻāpana ʻenehana
| ʻĀpana i manaʻo ʻia | SARS-CoV-2 IgM/IgG Antibody |
| Ka mahana mālama | 4 ℃-30 ℃ |
| ʻAno laʻana | Serum kanaka, plasma, koko venous a me ke koko manamana lima |
| Ola ola | 24 mahina |
| Nā mea kani kōkua | ʻAʻole koi ʻia |
| Nā mea hoʻohana hou aku | ʻAʻole koi ʻia |
| Ka manawa ʻike | 10-15 min |
| kikoo | ʻAʻohe hoʻololi keʻa me nā pathogens, e like me ka Human coronavirus SARSr-CoV, MERSr-CoV, HCoV-OC43, HCoV-229E, HCoV-HKU1, HCOV-NL63, H1N1, novel influenza A (H1N1) influenza virus (2009), H9N1 influenza virus (2009), H9N1 influenza virus, H1N1 influenza seasonal influenza B virus Yamagata, Victoria, respiratory syncytial virus A a me B, parainfluenza virus type 1,2,3, Rhinovirus A, B, C, adenovirus type 1,2,3,4,5,7,55. |
